These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2718607)

  • 41. Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus.
    Bertagnoli S; Gelfi J; Petit F; Vautherot JF; Rasschaert D; Laurent S; Le Gall G; Boilletot E; Chantal J; Boucraut-Baralon C
    Vaccine; 1996 Apr; 14(6):506-10. PubMed ID: 8782348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype.
    Buller RM; Smith GL; Cremer K; Notkins AL; Moss B
    Nature; 1985 Oct 31-Nov 6; 317(6040):813-5. PubMed ID: 4058585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Experimental study of residual virulence of viral vaccine strains].
    Makhlaĭ AA; Bektimirov TA; Borisevich SV; Mikhaĭlov VV; Perekrest VV; Podkuĭko VN; Kirillov VB; Levitov AT; Ruchko VM
    Vopr Virusol; 1999; 44(2):75-8. PubMed ID: 10358902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus.
    Berinstein A; Tami C; Taboga O; Smitsaart E; Carrillo E
    Vaccine; 2000 Apr; 18(21):2231-8. PubMed ID: 10717342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant vaccinia virus: immunization against multiple pathogens.
    Perkus ME; Piccini A; Lipinskas BR; Paoletti E
    Science; 1985 Sep; 229(4717):981-4. PubMed ID: 2992092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs.
    Chengalvala MV; Bhat BM; Bhat R; Lubeck MD; Mizutani S; Davis AR; Hung PP
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():125-31. PubMed ID: 8113721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uses of vaccinia virus in vaccine delivery.
    Ulaeto D; Hruby DE
    Curr Opin Biotechnol; 1994 Oct; 5(5):501-4. PubMed ID: 7765463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunizing effect of vaccinia virus expressing the nucleoprotein of rinderpest virus on systemic rinderpest virus infection in rabbits.
    Nakamura K; Ohishi K; Ohkubo S; Kamata H; Yamanouchi K; Fujiwara K; Kai C
    Comp Immunol Microbiol Infect Dis; 1998 Apr; 21(2):91-9. PubMed ID: 9611679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant vaccinia viruses as live vaccines.
    Smith GL
    Haematol Blood Transfus; 1987; 31():362-6. PubMed ID: 3443401
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New vaccines against hepatitis B.
    Papaevangelou G; Roumeliotou-Karayannis A
    Eur J Epidemiol; 1987 Mar; 3(1):1-4. PubMed ID: 2953625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene structures of low-neurovirulent vaccinia virus LC16m0, LC16m8, and their Lister original (LO) strains.
    Sugimoto M; Yasuda A; Miki K; Morita M; Suzuki K; Uchida N; Hashizume S
    Microbiol Immunol; 1985; 29(5):421-8. PubMed ID: 2993828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein-Barr virus membrane antigen gp340.
    Mackett M; Arrand JR
    EMBO J; 1985 Dec; 4(12):3229-34. PubMed ID: 3004944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus.
    Cheng KC; Smith GL; Moss B
    J Virol; 1986 Nov; 60(2):337-44. PubMed ID: 2430108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunological properties of recombinant HBsAg produced in yeast.
    Hauser P; Voet P; Simoen E; Thomas HC; Pêtre J; De Wilde M; Stephenne J
    Postgrad Med J; 1987; 63 Suppl 2():83-91. PubMed ID: 2446304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Production of 22 nm HBsAG particles by human lymphocytes infected with a recombinant vaccinia virus containing the coding sequence for hepatitis B virus surface antigen.
    Theilmann L; von Brunn A
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1479-84. PubMed ID: 1656954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hybrid vaccinia virus for mass hepatitis immunization?
    Beale AJ
    Nature; 1983 Apr; 302(5908):476-7. PubMed ID: 6835381
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes.
    Reuschel E; Jilg W; Seelbach-Goebel B; Deml L
    PLoS One; 2019; 14(2):e0212800. PubMed ID: 30794666
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Novel System for Constructing a Recombinant Highly-Attenuated Vaccinia Virus Strain (LC16m8) Expressing Foreign Genes and Its Application for the Generation of LC16m8-Based Vaccines against Herpes Simplex Virus 2.
    Omura N; Yoshikawa T; Fujii H; Shibamura M; Inagaki T; Kato H; Egawa K; Harada S; Yamada S; Takeyama H; Saijo M
    Jpn J Infect Dis; 2018 May; 71(3):229-233. PubMed ID: 29709968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model.
    Wyatt LS; Shors ST; Murphy BR; Moss B
    Vaccine; 1996 Oct; 14(15):1451-8. PubMed ID: 8994321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2.
    Flexner C; Moss B; London WT; Murphy BR
    Vaccine; 1990 Feb; 8(1):17-21. PubMed ID: 2316280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.